Cboe Global Markets
Cboe Global Markets' revenue rose 15.1% to $4.7 billion in fiscal 2025. Its operating margin was 31.1%, up from 26.8% a year earlier. Free cash flow was $1.7 billion, up 61.7%. It paid out $351 million in dividends and buybacks, 21% of free cash flow. The diluted share count fell 0.4%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
Revenue and margins
Net income and earnings per share
From fiscal 2016 to 2025, earnings per share grew 18.5% a year and net income 21.8% a year, as new shares raised the share count by 29% and diluted each share's earnings.
Returns on capital
Cash flow
Payouts and share count
Valuation
Two ways to value Cboe Global Markets yourself, both starting from its filings: a discounted cash flow model and the price-to-earnings method.
Discounted cash flow (DCF)
A discounted cash flow (DCF) model values a business as the cash it may generate in future, discounted back to today. The starting figures come from Cboe Global Markets' 10-K (or, for net cash and shares, its latest 10-Q) and the assumptions are yours: start from one of three example scenarios, then change any figure to see what it implies for a share, and how that compares with the last share price.
Value per share on three example scenarios, from Cboe Global Markets' fiscal 2025 free cash flow of $1.7B, net cash of $810M at December 31, 2025 and 105 million diluted shares, from its filings. The scenarios are fitted to Cboe Global Markets: the base scenario's growth in years 1 to 5 is its revenue growth over the last 3 years, 6.0% a year; the cautious and optimistic ones are lower and higher, and growth in years 6 to 10 is halfway to the long-run rate. The base scenario's discount rate is 9% for a business of moderate risk (Financial Exchanges & Data); the cautious and optimistic ones use a point more and a point less. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.
- Last close, October 26, 2026
- $335.25
- Value on these assumptions, against the last close
- —
- Cash flows in years 1 to 10, valued today
- —
- Everything after year 10, valued today
- —
- Plus net cash
- —
- Share of value from after year 10
How the value changes with two assumptions
Price-to-earnings (P/E) method
Another common way to value a company is to multiply its earnings per share by a price-to-earnings (P/E) multiple: the number of years of today's earnings an investor pays for a share. A higher multiple usually means investors expect earnings to grow. Choose a multiple, for example from similar companies, to see the value it gives.
Value per share on three example scenarios, from Cboe Global Markets' earnings per share of $12.83 (over the last four quarters). Each grows earnings for a year at the cash flow scenarios' rates and applies a multiple to next year's earnings: 26.1×, the middle of Cboe Global Markets' own P/E today, its peers' median and its sector's median (Cboe Global Markets' own P/E today) for the base scenario, 20% less and more for the cautious and optimistic ones. The price is brought back a year at 10%, 9% and 8%. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.
- Last close, October 26, 2026
- $335.25
- Value at this multiple, against the last close
- —
- Cboe Global Markets' P/E at the last close
- 26.1×
| Company | Last close | Earnings per share | P/E today |
|---|---|---|---|
| MSCIMSCI | $617.67 | $18.90 | 32.7× |
| Moody'sMCO | $484.45 | $16.41 | 29.5× |
| Cboe Global MarketsCBOE | $335.25 | $12.83 | 26.1× |
| CME GroupCME | $308.06 | $12.19 | 25.3× |
Balance sheet
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | 379 | 524 | 601 | 1,031 | 2,253 |
| Debt incl. finance leases | 1,299 | 1,742 | 1,439 | 1,441 | 1,443 |
| Net debt (negative means net cash) | 920 | 1,218 | 838 | 410 | −810 |
| Net debt to EBITDA | 0.9x | 1.9x | 0.7x | 0.3x | −0.5x |
| Debt to equity | 0.4x | 0.5x | 0.4x | 0.3x | 0.3x |
| Interest coverage | 16.8x | 8.2x | 16.9x | 21.3x | 28.1x |
| Current ratio | 1.3x | 1.1x | 1.4x | 1.8x | 1.9x |
| Quick ratio | 1.3x | 1.1x | 1.4x | 1.8x | 1.9x |
Insider trades
Over the 12 months between October 27, 2025 and October 26, 2026, no insider bought Cboe Global Markets shares on the open market, and 4 insiders sold $2.3 million, $699,320 of it under trading plans set up in advance.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 12, 2026 | Janet P FroetscherDirector | Sold plan | 937 | $278.95 | $261,376 | Form 4 |
| May 18, 2026 | Janet P FroetscherDirector | Sold plan | 1,223 | $358.09 | $437,944 | Form 4 |
| Feb 23, 2026 | Allen WilkinsonSVP, Chief Accounting Officer | Sold | 248 | $292.79 | $72,612 | Form 4 |
| Feb 18, 2026 | Edward J. FitzpatrickDirector | Sold | 3,947 | $285.87 | $1.1 million | Form 4 |
| Feb 18, 2026 | Alexander Matturri JRDirector | Sold | 1,500 | $285.36 | $428,040 | Form 4 |
Piotroski F-score
The F-score counts how many of nine simple tests of profitability, funding and efficiency a company passed in a year (Piotroski, 2000). The more tests passed, the stronger the year: 8 or 9 is strong, 0 to 2 weak. Companies that report no gross profit are scored on the other eight.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | Pass | Pass | Pass |
| Cash from operations is positive | Pass | Pass | Pass |
| Return on assets rose | Pass | Fail | Pass |
| Cash from operations exceeds net income | Pass | Pass | Pass |
| Debt fell relative to assets | Pass | Pass | Pass |
| Current ratio rose | Pass | Pass | Pass |
| Share count didn't rise | Pass | Pass | Pass |
| Gross margin rose | Pass | Fail | Pass |
| Revenue rose relative to assets | Fail | Pass | Pass |
| F-score | 8 of 9 | 7 of 9 | 9 of 9 |
| Accruals ratio | −4.3% | −4.4% | −7.6% |
Compare
Put Cboe Global Markets side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| Cboe Global Markets | FY25 | 15.1% | 31.1% | 35.7% | 22.8% | −0.5x | 9 | |
| CME Group | FY25 | 6.4% | 64.9% | 64.3% | 11.8% | −0.3x | 7 | Compare |
| MSCI | FY25 | 9.8% | 54.7% | 49.4% | 44.5% | 3.3x | 7 | Compare |
| Coinbase | FY25 | 9.4% | 20.0% | 31.9% | 14.5% | −2.4x | 4 | Compare |
| Moody's | FY25 | 8.9% | 43.4% | 33.4% | 31.1% | 1.2x | 9 | Compare |
10 years of figures
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | 703 | 2,229 | 2,769 | 2,496 | 3,427 | 3,495 | 3,958 | 3,774 | 4,094 | 4,714 |
| Revenue growth | 5.9% | 217.0% | 24.2% | −9.8% | 37.3% | 2.0% | 13.3% | −4.7% | 8.5% | 15.1% |
| Gross profit | 566 | 996 | 1,217 | 1,137 | 1,254 | 1,476 | 1,742 | 1,918 | 2,072 | 2,429 |
| Research and development | — | — | — | — | — | — | — | — | — | — |
| Operating income | 298 | 372 | 599 | 537 | 662 | 806 | 490 | 1,058 | 1,098 | 1,467 |
| Net income | 187 | 402 | 426 | 375 | 468 | 529 | 235 | 761 | 765 | 1,100 |
| Diluted EPS (US$) | 2.27 | 3.69 | 3.76 | 3.34 | 4.27 | 4.92 | 2.19 | 7.13 | 7.21 | 10.42 |
| Diluted shares (millions) | 81 | 108 | 112 | 112 | 109 | 107 | 107 | 106 | 106 | 105 |
| Cash flow | ||||||||||
| Cash from operations | 230 | 374 | 535 | 633 | 1,459 | 597 | 651 | 1,076 | 1,101 | 1,753 |
| Capital expenditure | 44 | 38 | 36 | 35 | 47 | 51 | 60 | 45 | 61 | 71 |
| Free cash flow | 185 | 337 | 498 | 598 | 1,411 | 546 | 591 | 1,031 | 1,040 | 1,682 |
| Dividends paid | 78 | 118 | 130 | 150 | 171 | 193 | 209 | 224 | 249 | 284 |
| Share buybacks | 60 | 0 | 141 | 157 | 349 | 81 | 101 | 84 | 205 | 67 |
| Acquisitions | 14 | 1,414 | 0 | 0 | 352 | 152 | 708 | 0 | 0 | 0 |
| Stock-based compensation | 14 | 53 | 35 | 22 | 22 | 27 | 31 | 41 | 42 | 50 |
| Balance sheet at fiscal year end | ||||||||||
| Cash and short-term investments | 97 | 191 | 311 | 300 | 338 | 379 | 524 | 601 | 1,031 | 2,253 |
| Debt incl. finance leases | — | 1,238 | 1,215 | 868 | 1,204 | 1,299 | 1,742 | 1,439 | 1,441 | 1,443 |
| Total assets | 477 | 5,266 | 5,321 | 5,114 | 6,516 | 6,814 | 6,999 | 7,488 | 7,789 | 9,305 |
| Total liabilities | 146 | 2,155 | 2,071 | 1,758 | 3,168 | 3,210 | 3,534 | 3,502 | 3,510 | 4,167 |
| Shareholders' equity | 318 | 3,111 | 3,241 | 3,356 | 3,349 | 3,605 | 3,465 | 3,985 | 4,280 | 5,138 |
| Margins and ratios | ||||||||||
| Gross margin | 80.6% | 44.7% | 44.0% | 45.5% | 36.6% | 42.2% | 44.0% | 50.8% | 50.6% | 51.5% |
| Operating margin | 42.4% | 16.7% | 21.6% | 21.5% | 19.3% | 23.1% | 12.4% | 28.0% | 26.8% | 31.1% |
| Net margin | 26.6% | 18.0% | 15.4% | 15.0% | 13.7% | 15.1% | 5.9% | 20.2% | 18.7% | 23.3% |
| Free cash flow margin | 26.3% | 15.1% | 18.0% | 23.9% | 41.2% | 15.6% | 14.9% | 27.3% | 25.4% | 35.7% |
| Return on capital | — | — | 10.8% | 9.8% | 11.5% | 12.9% | 5.8% | 16.2% | 16.3% | 22.8% |
| Return on equity | 64.7% | 23.4% | 13.4% | 11.4% | 14.0% | 15.2% | 6.7% | 20.4% | 18.5% | 23.4% |
| Return on assets | 43.4% | 14.0% | 8.1% | 7.2% | 8.1% | 7.9% | 3.4% | 10.5% | 10.0% | 12.9% |
| Net debt to EBITDA | — | 1.9x | 1.1x | 0.8x | 1.1x | 0.9x | 1.9x | 0.7x | 0.3x | −0.5x |